Prognostic Significance of Declining Ankle-brachial Index Values in Patients with Suspected or Known Peripheral Arterial Disease  by Feringa, H.H.H. et al.
Eur J Vasc Endovasc Surg 34, 206e213 (2007)
doi:10.1016/j.ejvs.2007.02.018, available online at http://www.sciencedirect.com onPrognostic Significance of Declining Ankle-brachial Index Values in
Patients with Suspected or Known Peripheral Arterial Disease
H.H.H. Feringa,1 S.E. Karagiannis,1 O. Schouten,2 R. Vidakovic,1 V.H. van Waning,3
E. Boersma,1 G. Welten,2 J.J. Bax4 and D. Poldermans4*
Departments of 1Cardiology, 2Vascular Surgery, and 3Anesthesiology,
Erasmus MC, Rotterdam, The Netherlands, and 4Department of Cardiology,
Leiden University Medical Center, Leiden, The Netherlands
Background. Peripheral arterial disease (PAD) is a risk factor for cardiovascular events. This study assessed the prognostic
significance of repeated ankle-brachial index (ABI) measurements at rest and after exercise in patients with PAD receiving
conservative treatment.
Methods. In a cohort study of 606 patients (mean age 62 12 years, 68% male), ABI at rest and after exercise was
measured at baseline and after 1 year. Patients with reductions in ABI were divided into three equally-sized groups (minor,
intermediate and major reductions) and were compared to patients without reductions. During a mean follow-up of
5 3 years, all-cause mortality, cardiac events, stroke and progression to kidney failure were noted.
Results. Death was recorded in 83 patients (14%) of which 49%were due to cardiac causes. Non-fatal myocardial infarction
occurred in 38 patients (6%), stroke in 46 (8%) and progression to kidney failure in 35 (6%). By multivariate analysis, pa-
tients with major declines in resting (>20%) and post-exercise (>30%) ABI were at increased risk of all-cause mortality
(HR: 3.3, 95% CI: 1.5e7.2, HR: 3.0, 95% CI: 1.4e6.4, respectively), cardiac events (HR: 3.1, 95% CI: 1.3e7.2, HR:
2.4, 95%CI: 1.1e5.6, respectively), stroke (HR: 4.2, 95%CI: 1.6e10.4, HR: 3.9, 95%CI: 1.4e10.2, respectively) and kidney
failure (HR: 2.7, 95% CI: 1.1e7.5, HR: 6.9, 95% CI: 1.5e31.5, respectively), compared to patients with no declines in ABI.
Conclusions. This study shows that major 1-year declines in resting and post-exercise ABI are associated with all-cause
mortality, cardiac events, stroke and kidney failure in patients with PAD.
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Peripheral arterial disease (PAD) is associated with an
increased risk of vascular morbidity and mortality
despite medical treatment.1e3 In the Netherlands,
the combined prevalence of symptomatic and asymp-
tomatic PAD in the population of 55 years and older is
19%.4 In the United States, prevalence rates for PAD
have been reported that range from 4% in patients
aged 40 years and older to 29% in patients aged
70 years and older.1,5e8 Therefore, the identification
of patients with PAD who are at increased risk of
late events is necessary for disease control and selec-
tion of appropriate treatment strategies.3,9,10
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pensive and non-invasive test used for the assessment
of lower extremity arterial obstruction and for screen-
ing of patients with suspected PAD.8e10 A resting ABI
of less than 0.90 has been associated with a 2- to 7-fold
increased risk of overall mortality and a 2- to 4-fold
increased risk of cardiovascular mortality, compared
to a resting ABI higher than 0.90.11e17 The prognostic
value of declines in ABI over time is not well known.
In this study, we assessed the association between
changes in resting and post-exercise ABI over time
and long-term outcome in patients with known or
suspected PAD who are receiving conservative (non-
surgical) treatment. We hypothesized that a larger de-
cline in both resting and post-exercise ABI would
identify patients at increased risk of all-cause mortal-
ity, cardiac events, stroke and end-stage renal disease,
irrespective of baseline ABI values and clinical risk
factors.rved.
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Study participants
We have prospectively included consecutive patients
with suspected or known lower extremity PAD who
were referred to our university clinic of vascular sur-
gery for the evaluation and management of their dis-
ease between January 1996 and January 2005. Patients
with known PAD had a resting or post-exercise ABI
0.90. In patients with suspected PAD, the diagnosis
was based on a typical history of intermittent claudi-
cation or other symptoms of chronic arterial insuffi-
ciency, including ulceration of the foot, hair loss or
reduced capillary refill. Patients unable to perform ex-
ercise, patients who underwent previous vascular sur-
gery and patients who had foot or leg amputations
were not included. We further considered patients
with ABI values greater than 1.50 to have calcified
atherosclerosis, resulting in high ABI readings. These
patients were also not included in the study. The hos-
pital’s Medical Ethical Committee approved the study
protocol and patients who fulfilled the inclusion crite-
ria agreed to participate in the study.
Co-morbidities
Based on hospital records and personal interviews at
the time of the visit, a medical history was recorded
including details of a previous myocardial infarction,
angina pectoris, coronary artery revascularization,
congestive heart failure, previous stroke or transient
ischemic attack, diabetes mellitus, hypertension,
smoking, hypercholesterolemia and renal dysfunc-
tion. Diabetes mellitus was recorded if patients pre-
sented with a fasting glucose level of 7.0 mmol/L,
or in those who required medical treatment. Hyper-
tension was recorded if patients presented with
a blood pressure 140/90 mmHg or if patients re-
ceived antihypertensive treatment. Hypercholesterol-
emia was recorded if patients presented with a
plasma cholesterol level 5.5 mmol/L, or if patients
were taking lipid-lowering agents. Renal dysfunction
was recorded if patients presented with a serum creat-
inine level 2.0 mg/dL (177 mmol/L) or in those who
required dialysis. Patients were assessed for chronic
cardiac medication use. A baseline 12-lead electro-
cardiography was obtained and the ABI at rest and
after exercise was measured in each patient.
Measurement of the ankle-brachial index
Trained technicians, using a Doppler ultrasonic in-
strument with an 8 MHz vascular probe (ImexdopCTþVascular Doppler, Miami Medical, USA), mea-
sured systolic blood pressures in the right and left
brachial artery, right and left dorsalis pedis artery
and right and left posterior tibial artery. The ABI in
the right and left leg was calculated by dividing the
right and the left ankle pressure by the brachial pres-
sure. The higher of the two brachial blood pressures
was used if a discrepancy in systolic blood pressure
was present. Again, the higher of the dorsalis pedis
and posterior tibial artery pressure was used when
a discrepancy in systolic blood pressure between the
two arteries was measured. If no pressure in the dor-
salis pedis artery was obtained due to an absent dor-
salis pedis artery, the pressure in the posterior tibial
artery was used. The ABI at rest was measured after
the participants had been resting in the supine posi-
tion for at least 10 minutes. Measurements were
then repeated at both sides with the patient in the su-
pine position, after 5 minutes of walking on a tread-
mill with a speed of 2.5 miles/hour. No inclining
plane or graded inclines were used with treadmill
testing, and the treadmill tests were performed
without continuous electrocardiographic monitoring
before, during and after testing. Inter- and intra-
observer agreement for resting ABI was 97% and
98%, respectively and for post-exercise ABI 96% and
97%, respectively.
Conservative versus surgical management
The decision for conservative management or surgical
intervention was at the discretion of the treating phy-
sician. In general, surgical treatment was indicated
when a significant improvement of symptoms could
be expected and when the expected benefits would
outweigh the risk of surgery. In patients who received
conservative treatment, i.e. walking exercise and/or
pharmacotherapy, ABI measurements were repeated
at least every year after enrollment. Patients who
died before the second ABI measurement and in
whom an ABI change over time could not be deter-
mined were excluded from the study (n¼ 13).
Follow-up
Follow-up ended at the date of the last visit or the
date of death. Information about the patient’s vital
status was obtained at the Office of Civil Registry.
For patients who died at our hospital during follow-
up, hospital records and autopsy results were
reviewed. For patients who died outside our hospital,
general practitioners were approached to ascertain the
cause of death. A cardiac cause of death was defined
Eur J Vasc Endovasc Surg Vol 34, August 2007
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mortem evidence of acute myocardial infarction or
definite criteria for myocardial infarction within the
four weeks before death), cardiac arrhythmias, con-
gestive heart failure, or sudden death. Details on
non-fatal myocardial infarction, stroke and end-stage
renal disease were obtained by regularly scheduled
follow-up visits. Additional information was obtained
by approaching the general practitioners or referring
clinicians. Non-fatal myocardial infarction was diag-
nosed when at least two of the following were pres-
ent: elevated cardiac enzyme levels (CK level >190
U/L and CK-MB >14 U/L, or CK-MB fraction >6%
of total CK, or cardiac troponin T> 0.1 ng/mL), de-
velopment of typical electrocardiographic changes
(new Q waves >1 mm or >30 ms), and typical symp-
toms of angina pectoris. Stroke was diagnosed when
patients presented with typical neurological symp-
toms lasting for more than 24 hours. In all cases of
stroke, the diagnosis was established by a neurologist.
End-stage renal disease was defined as an estimated
glomerular filtration rate less than 15 ml/min per
1.73 m2 or a need to start kidney replacement therapy,
which included dialysis or renal transplantation.
The estimated glomerular filtration rate was calcu-
lated using the following equation: glomerular filtra-
tion rate (ml/min/1.73 m2)¼ 186 (serum creatinine
level)1.154 (age)0.203 (0.742 if female) (1.210 if
of African descent).18
Statistical analysis
Continuous data are expressed as mean (þ/ SD) or
median (þ/ interquartile range) and compared us-
ing the Student t test or Mann-Whitney U test as ap-
propriate. Categorical data are presented as percent
frequencies and differences between proportions
were compared using the chi-square test with Yates’
correction. Comparisons of categorical variables with
continuous measures were calculated with analysis-
of-variance techniques. Initially, we compared pa-
tients receiving conservative treatment (n¼ 606) to
patients receiving lower extremity surgical revascu-
larization (n¼ 974). We then focused our analysis on
the 606 patients receiving conservative treatment to
assess the prognostic value of declines in ABI. The
change of the serial ABI measurements was calculated
in each leg and expressed as a percentage value. Of
the changes in ABI obtained in each leg, the lower
was used in all analyses. Although repeat ABI mea-
surements were obtained annually, the change in
ABI was calculated over the first year and expressed
as both percentage and absolute change. Only 1-year
Eur J Vasc Endovasc Surg Vol 34, August 2007changes were used in our analysis. Patients with
declining ABI were compared to patients with no
declines in ABI. Patients with declining ABI were
further divided into minor, intermediate and major
decline according to the tertiles as cut-off value (5%
and 20% for the decline in resting ABI and 6% and
30% for the decline in post-exercise ABI). For the pre-
diction of a major decline in ABI, a final set of baseline
variables was identified by multivariate analysis with
stepwise deletion of the least significant variable.
Only variables with a p 0.20 were retained in the
final model. The primary endpoints were overall mor-
tality and cardiac events (cardiac death or non-fatal
myocardial infarction). Secondary endpoints were
stroke and progression to end-stage renal disease.
For the outcome analysis, we used univariate and
multivariate Cox proportional hazard regression
models to analyze the association between ABI
decline and outcome. In multivariate analyses, all
clinical variables were entered, irrespective of the sig-
nificance level in univariate analysis. Hazard ratios
are given with 95% confidence intervals. For all tests,
a p value <0.05 (two-sided) was considered signifi-
cant. All analyses were performed using SPSS-11.0
statistical software (SPSS Inc., Chicago, Illinois).
Results
Conservative treatment versus surgical treatment
Baseline characteristics of patients receiving either
conservative or surgical treatment are presented in
Table 1. Patients receiving surgical treatment were
more likely to present with hypercholesterolemia,
hypertension, angina pectoris, chronic pulmonary dis-
ease and lower resting ABI values. Mean follow-up
was 5.3 3.3 years. In patients receiving surgical
and conservative treatment, death was recorded in
293 patients (30%) and 83 patients (14%), respectively.
As shown in Fig. 1, survival was significantly lower in
patients receiving surgical treatment.
Declines in ABI
In the 606 patients receiving conservative treatment,
the mean baseline ABI at rest (the lower of the right
and left ABI) was 0.69 0.23. A resting ABI >0.90 in
both legs was measured in 99 patients (16%). The
mean ABI measured after exercise (the lower of the
right and left ABI) was 0.48 0.29. A post-exercise
ABI >0.90 in both legs was observed in 59 patients
(10%). A total of 29 patients (5%) had both a resting
and post-exercise ABI of more than 0.90. These
209Declining Ankle-brachial Index Values in PAD29 patients all had a typical history of claudication
and signs of arterial insufficiency, including weak
peripheral pulses and reduced capillary refill. A total
of 459 patients (76%) had declining ABI values at rest
Table 1. Baseline characteristics of patients with peripheral arte-
rial disease receiving conservative management (n[ 606) and
patients receiving lower extremity revascularization surgery
(n[ 974)
Characteristic Conservative
management
(n¼ 606)
Surgical
treatment
(n¼ 974)
P
value
Age (years), mean þ/ SD 62 12 63 12 0.2
Male gender, No. (%) 414 (68) 709 (73) 0.06
Angina pectoris, No. (%) 112 (18) 250 (26) 0.001
Previous myocardial infarction,
No. (%)
200 (33) 351 (36) 0.2
History of heart failure, No. (%) 40 (7) 64 (7) 0.9
History of stroke, No. (%) 51 (8) 101 (10) 0.2
Diabetes mellitus, No. (%) 112 (19) 155 (16) 0.054
Hypercholesterolemia, No. (%) 147 (24) 292 (30) 0.02
Hypertension, No. (%) 222 (37) 470 (48) <0.001
Current smoking, No. (%) 169 (28) 289 (30) 0.5
Renal dysfunction, No. (%) 31 (5) 59 (6) 0.5
Chronic pulmonary disease,
No. (%)
57 (9) 145 (15) 0.002
Rest ankle-brachial index,
mean þ/ SD
0.69 0.23 0.65 0.24 0.03
Post-exercise ankle-brachial
index, mean þ/ SD
0.48 0.29 0.46 0.29 0.3
Aspirin, No. (%) 179 (30) 297 (30) 0.7
Angiotensin-converting enzyme
inhibitors, No. (%)
174 (29) 290 (30) 0.7
b-blockers, No. (%) 193 (32) 355 (36) 0.07
Statins, No. (%) 218 (36) 329 (34) 0.4
Fig. 1. Kaplan-Meier survival curves in 1580 patients with
peripheral arterial disease according to conservative treat-
ment or surgical intervention.and 456 patients (75%) had declining ABI values after
exercise. Declining ABI values at rest were observed
in 67 (68%) out of 99 patients with a normal resting
ABI (ABI >0.90). Declining ABI values after exercise
were observed in 40 (68%) out of 59 patients with
normal post-exercise ABI (ABI>0.90). The median
change in resting ABI in patients with no declining
ABI was þ13% and in patients with declining ABI
12%. The median change in post-exercise ABI in
patients with no declining ABI was þ21% and in
patients with declining ABI 17%.
Predictors of declines in ABI values
Significant predictors of major declines in resting ABI
values (>20%) were age (p¼ 0.003), cigarette smoking
(p< 0.001), history of stroke (p< 0.001) and a previous
myocardial infarction (p¼ 0.042) (Fig. 2). Significant
predictors of major declines in post-exercise ABI
values (>30%) were age (p< 0.001), diabetes mellitus
(p< 0.001), cigarette smoking (p< 0.001) and a history
of stroke (p¼ 0.031) (Fig. 2).
Predictive value of declines in ABI
Of the 83 patients receiving conservative treatment
who died during follow-up, 49% were due to cardiac
causes (41 patients). Non-fatal myocardial infarction
occurred in 38 patients (6%), stroke in 46 patients
(8%) and progression to end-stage renal disease in
35 patients (6%). Fig. 3 shows the incidence of overall
mortality, cardiac events, stroke and progression to
end-stage renal disease in patients with no, minor, in-
termediate and major declines in resting and post-
exercise ABI. By univariate analysis, patients with
major declines in resting and post-exercise ABI had
the highest hazard of all-cause mortality, cardiac
events, stroke and end-stage renal disease (Table 2).
Patients with intermediate declines in resting and
post-exercise ABI were also at significantly increased
risk of death and cardiac events (Table 2). After
adjustment for baseline clinical variables, baseline
ankle-brachial index values, b-blockers, statins, aspirin
and angiotensin-converting enzyme inhibitors, major
declines in resting and post-exercise ABI remained
significantly associated with all-cause mortality, car-
diac events, stroke and kidney failure (Table 2). Inter-
mediate declines remained significantly associated
with death and cardiac events (Table 2). As demon-
strated in Table 3, absolute declines in ABI (per
0.10 decline) were significantly associated with all-
cause mortality, cardiac events, stroke and end-stage
renal disease.
Eur J Vasc Endovasc Surg Vol 34, August 2007
210 H. H. H. Feringa et al.Fig. 2. Baseline clinical variables associated with a major 1-year decline in resting ankle-brachial index (ABI) (decline of more
than 20%) and post-exercise ankle-brachial index (decline of more than 30%) in patients with peripheral arterial disease
receiving conservative management.Discussion
The current study found that major declines in resting
and post-exercise ABI values are significantly associ-
ated with increased long-term mortality, cardiac
events, stroke and progression to end-stage renal dis-
ease. These findings were independent of baseline
ABI values, established clinical risk factors and car-
diovascular therapy.
Given the fact that the presence of PAD should be
regarded as a marker of atherosclerosis in other vas-
cular beds, it is not surprising that many of these pa-
tients die due to cardiovascular disease, stroke or
renal dysfunction.10 The management of PAD com-
prises of walking exercise, aggressive management
of risk factors, life-style modifications, antiplatelet
therapy and statins.19 Patients who have extensive
functional disability, who are unresponsive to exercise
or pharmacotherapy, and who have a reasonable like-
lihood of symptomatic improvement may benefit
from surgical intervention.19 The higher mortality
rate in patients undergoing surgery in relation to con-
servative management may be explained by the pres-
ence of more co-morbidities. The high prevalence andEur J Vasc Endovasc Surg Vol 34, August 2007associated morbidity and mortality of PAD in the gen-
eral population warrants the identification of patients
at increased risk so that preventive measures can be
applied to reduce the incidence of atherosclerosis
related complications.
Large cohort studies have consistently demon-
strated that lower ABI values are associated with
increased mortality and cardiovascular events. In
a study of Leng and colleagues, a significant linear in-
crease in mortality across decreasing ABI categories
was observed using resting ABI cut-off values of
1.10, 1.00, 0.90 and 0.70.17 We have previously demon-
strated that the adjusted risk for overall mortality in-
creased by 8% for every 0.10 decrease of the resting
ABI, and by 9% for every 0.10 decrease of the post-
exercise ABI. The adjusted risk for cardiac death in-
creased by 12% and 15% for every 0.10 decrease of
the resting ABI and post-exercise ABI, respectively.20
The concept that PAD is a marker of generalized
atherosclerosis has been reflected by the fact that
ABI values correlate with the extent of angiographic
coronary artery disease.21 The prognostic value of
post-exercise ABI has been supported by the view
that a healthy person can maintain ankle systolic
211Declining Ankle-brachial Index Values in PADpressures at normal levels during modest workloads,
but that larger falls in systolic pressure in the legs are
measured during low levels of workload in patients
with more extensive PAD.22e24 Based on the greater
accuracy of the postexercise ABI to detect PAD, the
American College of Cardiology/American Heart
Association has recommended its use, especially in
patients with suspected PAD who have normal
resting ABI values.19
Important predictors of declining ABI values in our
study included advanced age and smoking.Our results
are supported by the Cardiovascular Health study,
which found that advanced age, smoking,male gender,
hypertension and higher LDL-cholesterol concentra-
tions were risk factors for declines in ABI.25 Smoking
was also identified as a strong predictor of large vessel
peripheral arterial disease in a study by Aboyans and
colleagues.26 We found that diabetes only predicted
Fig. 3. Absolute event rate during follow-up according
to the 1-year decline in resting (minor decline: 1e5%,
intermediate decline: 6e20%, major decline: >20%) and
post-exercise ankle-brachial index (minor decline: 1e6%,
intermediate decline: 7e30%, major decline: >30%) in
patients with peripheral arterial disease receiving conserva-
tive medical management.T
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212 H. H. H. Feringa et al.major declines in post-exercise ABI in contrast to rest-
ingABI. Similarly, diabeteswasnot a significant predic-
tor of ABI decline,25 of large vessel PAD progression26
and of declines in post-exercise ABI.27 In the current
study, however, a significant correlation between dia-
betes and major declines in post-exercise ABI was
found. Concomitant arterial wall stiffening,medial cal-
cinosis and higher ankle systolic pressures in diabetic
patients may mask arterial occlusive disease, leading
to pseudo-normal resting ABI values. We speculate
that the value of postexercise ABI lies in its ability to
measure larger decreases in ankle systolic pressures
in the presence of atherosclerotic obstructive lesions,
and that obstructive arterial disease can become more
evident after exercise in diabetic patients.
To our knowledge, the current study is the first to
describe the association between declines in ABI and
prognosis in patients with PAD receiving conservative
treatment. Declines in ABI may reflect active and pro-
gressive atherosclerosis, precipitating acute coronary
and cerebrovascular events. The association between
progression in atherosclerosis and progression to kid-
ney failure is less well-defined. The Atherosclerosis
Risk in Communities Study showed that patients
with an ABI of 0.90e0.99 and <0.90 were at increased
risk of serum creatinine increases over a 3-year time
period, compared to patients with ABI values above
Table 3. The long-term prognostic value of absolute declines in
ankle-brachial index values in multivariate analysis in patients
with peripheral arterial disease receiving conservative
management
Resting ABI
per 0.10 decline
Postexercise ABI
per 0.10 decline
All-cause mortality
 Unadjusted Hazard
Ratio (95% CI)
1.12 (1.01e1.26) 1.12 (1.02e1.25)
 Adjusted Hazard
Ratio (95% CI)*
1.13 (1.01e1.26) 1.11 (1.01e1.23)
Cardiac events
 Unadjusted Hazard
Ratio (95% CI)
1.17 (1.05e1.31) 1.15 (1.03e1.30)
 Adjusted Hazard
Ratio (95% CI)*
1.18 (1.05e1.33) 1.17 (1.04e1.33)
Stroke
 Unadjusted Hazard
Ratio (95% CI)
1.30 (1.14e1.48) 1.24 (1.09e1.40)
 Adjusted Hazard
Ratio (95% CI)*
1.35 (1.18e1.55) 1.22 (1.06e1.38)
End-stage renal disease
 Unadjusted Hazard
Ratio (95% CI)
1.20 (1.02e1.41) 1.19 (1.03e1.38)
 Adjusted Hazard
Ratio (95% CI)*
1.20 (1.03e1.41) 1.18 (1.02e1.36)
* Adjusted for age, gender, coronary artery disease, history of
heart failure, history of stroke, diabetes, hypercholesterolemia,
hypertension, smoking, renal dysfunction, baseline ankle-brachial
index values and cardioprotective medication.
Eur J Vasc Endovasc Surg Vol 34, August 20071.00.28 It has been proposed that atherosclerosis
has indirect effects on the kidney because of athero-
sclerotic lesions in the renal artery and that athero-
sclerosis or atherogenic factors may induce directly
intrarenal microvascular disease and renal injury.29
Repeated measurements of resting and post-exercise
ABI values are simple, inexpensive and non-invasive.
Results from this study suggest that repeated ABI mea-
surements at rest and after exercisemay be incorporated
among other tools for identifying patients at increased
risk of late events. Either resting and post-exercise ABI
declines after 1 year can identify a subgroup of patients
at increased risk. Post-exercise ABI testing may be use-
ful in patients with no declines in serial resting ABI.
Therefore, both methods may be recommended.
Patients with major declines in ABI values may be
referred for further cardiovascular, cerebrovascular or
renal evaluation and may subsequently benefit from
preventive pharmacologic and non-pharmacologic
interventions.
Several limitations of this study should be ad-
dressed. It should be emphasized that the event rate
in the groups of patients with different declines in
ABI was relatively small which may have affected
the statistical power of the study. However, the hazard
of adverse events was consistently increased in those
with major declines in resting and post-exercise ABI.
Secondly, the results apply to patients referred to
a university hospital. These patients may have a
higher risk profile compared to patients with sus-
pected or known PAD in the general population.
In conclusion, this observational cohort study of
patients with PAD receiving conservative treatment
shows that major declines in resting and post-exercise
ABI are associated with late overall mortality, cardiac
events, stroke and end-stage renal disease. The results
support the view that progression of atherosclerosis in
the lower extremities is associated with morbidity in
the coronary, cerebrovascular and renal circulation.
Repeated measurements of resting and post-exercise
ABI are simple and non-invasive and should be con-
sidered in the follow-up of patients with PAD receiv-
ing conservative treatment for identifying those at
increased risk of adverse events and for enabling
optimal prevention of complications.
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